Featured Story | | | Friday, August 25, 2017 Regenxbio penned a deal to acquire Dimension Therapeutics. The takeover will see Regenxbio pay about $86 million to add two early-stage gene therapies to its pipeline. |
|
|
| This week's sponsor is FierceBiotech Drug Development Forum. | | | Save 15% on the FierceBiotech 2nd Drug Development Forum
Network with 300+ biotech leaders and 90+ executive-level speakers at the largest biotech conference for optimizing pipeline strategies, partnerships and deal making September 25-27 in Boston, MA. Sign up today & save 15% w/ code C942FIERCE. |
Top Stories Friday, August 25, 2017 Nasdaq hit Auris Medical with another noncompliance notice. The stock exchange has given Auris until Oct. 2 to meet the stockholders’ equity requirement, a few days more than it has to regain compliance with the minimum bid price rule. Friday, August 25, 2017 It's been a good summer for Apellis, which has just reported positive mid-stage data for its lead candidate in age-related macular degeneration a couple of weeks after it raised $60 million in a series E round. Friday, August 25, 2017 Baylor College-led researchers used a cell culture-based screening method to single out a potential target for the treatment of a neurological condition characterized by moderate to severe intellectual disability. Their findings could be useful in treating autism and other neurological conditions. Friday, August 25, 2017 Shire has signed up to support the development of an app for patients with hemophilia A and B. The agreement will see Shire contribute to the development of features tailored to the needs of patients who have inhibitors against clotting factor concentrates. Thursday, August 24, 2017 In this week's EuroBiotech Report, Lilly pens a deal with Topas, AstraZeneca buys into mRNA research and development, BenevolentAI poaches an executive from GlaxoSmithKline and more. Friday, August 25, 2017 Samsung is tapping into novel drug R&D through a co-development deal with Takeda, GlaxoSmithKline has partnered with e-commerce giant Alibaba to help boost Cervarix uptake in China and Gland Pharma is said to be lowering the stake to be sold to Fosun so that the M&A deal can pass regulatory authorities. Friday, August 25, 2017 CFO Jeff Poulton will leave Shire at the end of this year, Novartis appointed Bertrand Bodson from retailer Sainsbury's Argos as chief digital officer, ex-Zealand Pharma chief David Horn Solomon will take the top role at troubled Akari, plus more hirings, firings and retirings throughout the industry. | This week's sponsor is FierceBiotech. | | | FierceBiotech Executive Summit- London
Join FierceBiotech for our third annual Executive Summit in London. We'll gather the experts together to discuss innovation around R&D in the UK and look ahead to what's in store for 2018 with leaders in the field discussing trends in the industry. |
Resources Sponsored by: Veeva Learn why 99% of respondents report the need to unify their clinical applications, including CTMS, EDC, eTMF, and study start-up. Presented By: MPI Research FierceBiotech interviews Dr. DeWit to discuss a common cause for drug development delays, and strategies to avoid these costly setbacks. Sponsored by: Veeva Learn why 99% of respondents report the need to unify their clinical applications, including CTMS, EDC, eTMF, and study start-up. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored by: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. 2nd Strategic Partnerships for Drug Repurposing Oct 26-27 | Boston, MA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London Hear from 130+ Experts Leading the Way in Life Science Marketing October 3-6, 2017 | Philadelphia, PA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA |
